Andorra vs Papua New Guinea: Statin use vs average non hdl cholesterol levels
Andorra
3.6
in 2018
Papua New Guinea
3.6
in 2018
Andorra rank
30th
Papua New Guinea rank
30th
Statin use vs average non hdl cholesterol levels over time
- Andorra
- Papua New Guinea
How they compare
Andorra currently reports 3.6 against 3.6 in Papua New Guinea, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Andorra ahead.
Andorra ranks 30th and Papua New Guinea ranks 30th of 191 countries.
Andorra has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Andorra | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.67 | 3.33 | 1.34 | Andorra |
| 1990s | 4.32 | 3.48 | 0.84 | Andorra |
| 2000s | 3.95 | 3.54 | 0.41 | Andorra |
| 2010s | 3.67 | 3.6 | 0.0667 | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, Andorra or Papua New Guinea?
- Andorra, at 3.6 against 3.6 in Papua New Guinea as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between Andorra and Papua New Guinea?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Papua New Guinea?
- 39 years are reported by both, from 1980 to 2018.
- How do Andorra and Papua New Guinea rank globally for statin use vs average non hdl cholesterol levels?
- Andorra ranks 30th and Papua New Guinea ranks 30th of 191 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.